Ekberg, Henrik, Qi, Zhongquan, Pahlman, Clara, Veress, Béla, Bundick, Robert, Craggs, Robert, ...
Abstract is not available
Oderup, Cecilia, Malm, Helene, Ekberg, Henrik, Qi, Zhongquan, Veress, Béla, Ivars, Fredrik, ...
Abstract is not available
Zaina, Silvio, Pettersson, Linda, Thomsen, Anne Bloch, Chai, Chun-Ming, Qi, Zhongquan, Thyberg, Johan, ...
Abstract is not available
Corbascio, Matthias, Mahanty, Harish, Osterholm, Cecilia, Qi, Zhongquan, Pearson, Thomas C, Larsen, Christian P, ...
BACKGROUND: Blockade of CD40 ligand (CD40L; CD154, gp39) is a potential treatment for autoimmune disease and allograft rejection. However, CD40L-/- mice are capable of mobilizing cellular immune...
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. (2002)
Corbascio, Matthias, Ekstrand, Helene, Osterholm, Cecilia, Qi, Zhongquan, Simanaitis, Mecislovas, Larsen, Christian P, ...
CTLA4Ig and anti-LFA-1 are members of a new generation of immunomodulatory drugs which inhibit important signaling pathways in T cell activation. Both substances target molecules which have pivitol...
In clinical transplantation immunosuppressive agents are used in combination with the objective to achieve additive effects and less toxicity. A large number of novel drugs are candidates for...
In clinical transplantation immunosuppressive agents are used in combination with the objective to achieve additive effects and less toxicity. A large number of novel drugs are candidates for...